GlassScriptPhysician profile
Trinh Hoang
NPI 1649892357
$10,554.10
in general payments reported to CMS, 2019-2025
39 companies · $3,300 in 2025
The $3,300 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $405 · 2022: $2,086 · 2023: $1,911 · 2024: $2,853 · 2025: $3,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,752 · Education: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,752.33 |
| Education | $311.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,520.62 | 2022-2025 | Tavneos, Evenity, Otezla |
| Astrazeneca Pharmaceuticals LP | $1,473.76 | 2021-2025 | Saphnelo, Fasenra, Tezspire |
| Abbvie INC. | $1,147.10 | 2022-2025 | |
| Glaxosmithkline, LLC. | $747.45 | 2021-2025 | Benlysta, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $558.59 | 2022-2023 | Dupixent |
| Genzyme Corporation | $532.87 | 2022-2025 | |
| Ucb, INC. | $525.83 | 2023-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $501.01 | 2022-2025 | |
| Janssen Biotech, INC. | $388.89 | 2023-2025 | Tremfya, Simponi Aria |
| Mallinckrodt Hospital Products INC. | $373.87 | 2024-2025 | Acthar |
| Pfizer INC. | $356.98 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $255.37 | 2024-2025 | Purified Cortrophin Gel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.00 | 2021-2025 | Ofev, Cyltezo |
| Grifols USA, LLC | $187.24 | 2023-2025 | Xembify, Gamunex-C |
| Optinose US, INC. | $163.97 | 2022-2023 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $154.69 | 2024-2025 | Orencia |
| Sanofi-Aventis U.S. LLC | $153.95 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $137.26 | 2024-2025 | Strensiq |
| Radius Health, INC. | $129.92 | 2024-2025 | Tymlos |
| Leo Pharma INC. | $118.49 | 2023 | Adbry |
| Aimmune Therapeutics, INC. | $115.64 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $103.53 | 2022-2024 | Takhzyro, Cuvitru |
| Electromed, INC. | $93.21 | 2021-2022 | |
| Sobi, INC | $85.49 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $70.40 | 2022-2024 | Truxima |
| Alk-Abello, INC | $60.80 | 2022-2023 | Odactra, Ragwitek, Grastek |
| Csl Behring | $46.42 | 2023 | Hizentra |
| Organon LLC | $45.96 | 2024-2025 | Renflexis, Hadlima |
| Genentech USA, INC. | $30.00 | 2024-2025 | Actemra |
| Tersera Therapeutics LLC | $29.04 | 2025 | Quzyttir |
| Pharming Healthcare, INC. | $27.60 | 2022 | |
| Kaleo, INC. | $27.59 | 2022-2023 | Auvi-Q |
| Invivyd INC | $26.46 | 2025 | Pemgarda |
| Biocon Biologics INC | $24.50 | 2023 | Hulio |
| Lilly USA, LLC | $22.78 | 2024 | Taltz |
| Advanced Respiratory, INC | $20.23 | 2021 | |
| Octapharma USA, INC. | $18.82 | 2025 | Octagam Immune Globulin (Human) |
| Aurinia Pharma U.S., INC. | $18.61 | 2024 | Lupkynis |
| Insmed, INC. | $15.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trinh Hoang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.